Stockscreener 앱 받기
1.05
8.70%
-0.10
시간 외 거래:
1.10
0.05
+4.76%
전일 마감가:
$1.15
열려 있는:
$1.19
하루 거래량:
242.14K
Relative Volume:
1.29
시가총액:
$6.22M
수익:
-
순이익/손실:
$-15.52M
주가수익비율:
-0.0565
EPS:
-18.58
순현금흐름:
$-16.61M
1주 성능:
+1.45%
1개월 성능:
+6.92%
6개월 성능:
+30.43%
1년 성능:
-84.09%
1일 변동 폭
$1.01
$1.19
1주일 범위
$1.01
$1.20
52주 변동 폭
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
명칭
Revelation Biosciences Inc
전화
650-800-3717
주소
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
REVB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.05 | 6.81M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revelation Biosciences Inc 주식(REVB)의 최신 뉴스
Revelation Biosciences sets warrant expiration after stockholder approval - Investing.com
Why Revelation Biosciences Inc. stock remains a top recommendationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting - azcentral.com and The Arizona Republic
Revelation Biosciences shareholders approve warrant issuance and meeting adjournment By Investing.com - Investing.com Canada
Revelation Biosciences, Inc. (REVB) -5.1% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Revelation Biosciences shareholders approve warrant issuance and meeting adjournment - Investing.com
Revelation Biosciences (REVB) Stock Analysis Report | Financials & Insights - Benzinga
Revelation Biosciences (NASDAQ: REVB) secures quorum ahead of Dec. 3 vote, notes $9.6M proceeds - Stock Titan
Revelation Biosciences on track for end-of-phase 1 meeting later this year - MSN
Revelation Biosciences (NASDAQ:REVB) Shares Up 2.4% – Here’s Why - Defense World
Revelation Biosciences, Inc. (REVB) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Earnings Flash (REVB) Revolution Beauty Group Reports Fiscal H1 Revenue GBP49.4M - marketscreener.com
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - The State Journal-Register
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - The Courier-Journal
Can Revelation Biosciences Inc. Equity Warrant stock sustain free cash flow growthLong Setup & Accurate Entry/Exit Alerts - newser.com
How Revelation Biosciences Inc. stock reacts to global recession fearsJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Revelation Biosciences submits end-of-phase 1 package to FDA By Investing.com - Investing.com Australia
Revelation Says On Track for FDA Meeting Later This Year - MarketScreener
Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com
Revelation Biosciences (NASDAQ: REVB) Advances Gemini AKI Program With FDA Phase 1 Meeting - Stock Titan
Chart based analysis of Revelation Biosciences Inc. Equity Warrant trends2025 Valuation Update & Precise Buy Zone Identification - newser.com
How Revelation Biosciences Inc. Equity Warrant stock performs in weak economyGold Moves & Short-Term Trading Alerts - newser.com
How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
Using RSI to spot recovery in Revelation Biosciences Inc. Equity Warrant2025 Market Trends & Expert Curated Trade Ideas - newser.com
Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity Warrant2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Revelation Biosciences Inc (REVB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):